Director, Pharmaceutical Development

Director, Pharmaceutical Development

Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI‑integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements.

Nurix aims to establish degrader‑based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease.

Nurix Therapeutics, Inc. is seeking a highly experienced Director of Pharmaceutical Development. The role leads small molecule drug product development focused on oral and topical dosage forms. Responsibilities span QbD‑based formulation and process development from early phase through commercial launch. The position requires strong cross‑functional collaboration and hands‑on CDMO management. This position is on site in the Brisbane, CA office.

• Lead QbD‑based formulation and process development for small molecule drug programs with a focus on oral and topical dosage forms across all development phases.
• Apply expertise in BCS Class II/IV compound development and enabling formulation technologies, including amorphous solid dispersions (spray‑dried dispersions, hot‑melt extrusion), lipid‑based drug delivery systems (SMEDDS, SEDDS, lipid suspensions), and nano‑formulations to address solubility and bioavailability challenges.
• Define and document the Quality Target Product Profile (QTPP) and identify Critical Quality Attributes (CQAs) to guide formulation strategy.
• Conduct systematic risk assessments to identify Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs) using FMEA and other risk assessment tools.
• Develop and optimize manufacturing processes appropriate to the dosage form, ensuring scalability and process robustness.

• Lead manufacturing scale‑up activities from laboratory to pilot and commercial scale, ensuring robust and reproducible processes.
• Troubleshoot manufacturing deviations, out‑of‑specification results, and process failures; drive root cause analysis and implement corrective actions.

• Drive late‑stage development activities (Phase 2b through commercial launch) including clinical supply manufacturing, process performance qualification (PPQ), and continued process verification (CPV).
• Author and review CMC sections of regulatory submissions including INDs, NDAs, and MAAs.
• Ensure all development activities comply with current GMP regulations and internal quality standards.

• Manage external CDMO partnerships, including vendor qualification, technical oversight, and performance governance to ensure project timelines, quality standards, and budget commitments are met.
• Serve as the primary technical point of contact between pharmaceutical development and cross‑functional teams including Analytical Development, Clinical Operations, Regulatory Affairs, Quality, Supply Chain, and Commercial.
• Provide scientific leadership and mentorship to junior scientists, associates, and project team members.

• Ph.D. in Pharmaceutical Sciences, Pharmaceutics, Chemical Engineering, Chemistry, or a closely related discipline strongly preferred with 12 years of industry experience.
• 12+ years of progressive pharmaceutical development experience in an industry setting (biotechnology, pharmaceutical, or CDMO).
• Deep expertise in small molecule drug product development with a focus on oral and topical dosage forms, especially enabled formulation development (e.g., amorphous solid dispersions, lipid‑based systems, nano‑formulations).
• Comprehensive hands‑on experience with QbD methodologies: QTPP definition, CQA identification, CMA/CPP risk assessment, DoE, design space…